| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 15 |
| 1 | OMEPRAZOLE MAGNESIUM | 9 |
| 2 | BEVACIZUMAB | 8 |
| 3 | FOLIC ACID | 8 |
| 4 | OMEPRAZOLE | 8 |
| 5 | OXALIPLATIN | 8 |
| 6 | CABOZANTINIB | 7 |
| 7 | ETANERCEPT | 7 |
| 8 | MYCOPHENOLATE MOFETIL | 7 |
| 9 | RAMUCIRUMAB | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RAMUCIRUMAB | 7 | 0.0011 |
| 1 | GINKGO BILOBA | 1 | 0.0007 |
| 2 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 3 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 4 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 3 | 0.0004 |
| 5 | PANITUMUMAB | 5 | 0.0003 |
| 6 | ACARBOSE | 1 | 0.0003 |
| 7 | NALOXEGOL OXALATE | 1 | 0.0003 |
| 8 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 9 | COBIMETINIB | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 7 | 0.0011 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 15 | 0.0002 |
| 3 | Bile Acid [EPC] | 3 | 0.0001 |
| 4 | Aluminum Complex [EPC] | 3 | 0.0001 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 5 | 0.0001 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 8 | Potassium Binder [EPC] | 1 | 0.0001 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 3 | 0.0001 |